Qingdao Vland Biotech Co Ltd (603739) — Capital Reinvestment Ratio
Qingdao Vland Biotech Co Ltd (603739) has a Capital Reinvestment Ratio of 0.31x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥24.29 Million) in capital expenditures (CN¥7.42 Million). Check tangible net worth ratio of Qingdao Vland Biotech Co Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Qingdao Vland Biotech Co Ltd Capital Reinvestment Ratio (2014–2024)
This chart tracks Qingdao Vland Biotech Co Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see Qingdao Vland Biotech Co Ltd (603739) cash flow conversion.
Annual Capital Reinvestment Ratio for Qingdao Vland Biotech Co Ltd (2014–2024)
Year-by-year Capital Reinvestment Ratio for Qingdao Vland Biotech Co Ltd from 2014 to 2024. See Qingdao Vland Biotech Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.54x | CN¥195.41 Million | CN¥104.72 Million | ▼ -61.8% |
| 2023 | 1.40x | CN¥153.59 Million | CN¥215.64 Million | ▼ -60.9% |
| 2022 | 3.59x | CN¥95.31 Million | CN¥342.02 Million | ▼ -34.9% |
| 2021 | 5.51x | CN¥89.51 Million | CN¥493.58 Million | ▲ +350.3% |
| 2020 | 1.22x | CN¥173.00 Million | CN¥211.83 Million | ▼ -33.4% |
| 2019 | 1.84x | CN¥65.33 Million | CN¥120.17 Million | ▲ +120.4% |
| 2018 | 0.83x | CN¥85.75 Million | CN¥71.56 Million | ▲ +75.3% |
| 2017 | 0.48x | CN¥121.90 Million | CN¥58.05 Million | ▲ +177.1% |
| 2016 | 0.17x | CN¥154.49 Million | CN¥26.55 Million | ▼ -76.9% |
| 2015 | 0.74x | CN¥74.27 Million | CN¥55.32 Million | ▼ -14.4% |
| 2014 | 0.87x | CN¥58.55 Million | CN¥50.93 Million | — |